These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4965686)

  • 21. [Preliminary report on the second short-course study in pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Aug; 7(4):198-202, 253. PubMed ID: 6543766
    [No Abstract]   [Full Text] [Related]  

  • 22. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course treatment in pulmonary tuberculosis.
    East Afr Med J; 1973 Dec; 50(12):672-80. PubMed ID: 4132127
    [No Abstract]   [Full Text] [Related]  

  • 24. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
    J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
    Rudoĭ NM; Erkovskaia OIu
    Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
    [No Abstract]   [Full Text] [Related]  

  • 26. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 27. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of the bacteriological study of the associated bacterial flora of the sputum of patients with chronic pulmonary tuberculosis].
    Boccitto G; Salvati F; De Ritis G
    Policlinico Prat; 1970 Apr; 77(15):477-89. PubMed ID: 4987995
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of tuberculosis.
    Harris AA; Karakusis P
    Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
    [No Abstract]   [Full Text] [Related]  

  • 31. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficiency of massive antibacterial therapy in patients with far advanced destructive forms of pulmonary tuberculosis].
    Ianovskaia LM
    Probl Tuberk; 1966; 44(6):28-33. PubMed ID: 4968674
    [No Abstract]   [Full Text] [Related]  

  • 34. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):39-45. PubMed ID: 4979932
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of the study "Intermittent therapy of tuberculosis within therapeutic health centers"].
    Cavić L; Kaleta J; Sazdanić D; Krstić M
    Nar Zdrav; 1972; 28(7):230-5. PubMed ID: 4633209
    [No Abstract]   [Full Text] [Related]  

  • 36. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
    Clancy LJ; Kelly P; O'Reilly L; Byrne C; Costello E
    Eur Respir J; 1990 Apr; 3(4):399-402. PubMed ID: 2114307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis.
    Adkinson BC; De La Fuente J; Ninneman M; Chuadry ZA; Adkinson BD; Khalid L
    Int J Infect Dis; 2020 Nov; 100():411-413. PubMed ID: 32987178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intermittent 2-phase therapy using ethambutol-INH-streptomycin].
    Eule H; Fichtner K; Gross V; Sellau J
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):139-57. PubMed ID: 4627225
    [No Abstract]   [Full Text] [Related]  

  • 40. [CONGENITAL TUBERCULOSIS IN PRETERM NEWBORN].
    Syvoplias-Romanova GS; Klymenko VA; Piontkovskaia OV; Perkhun MI; Zoria OA
    Lik Sprava; 2015; (1-2):155-6. PubMed ID: 26118059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.